CoChat

Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer

Open access
Chen, Shuo-Fu, Ng, Pui-Lam, Lai, Chen-Wei, Wang, Fu-Jia, Wang, Yu-Chi, Chen, Ming-Hong, Tung, Fu-I, Liu, Tse-Ying · 2025 · Journal of Nanobiotechnology

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Radiotherapy plays an important role in the treatment of triple-negative breast cancer, yet its ability to trigger systemic responses against distant tumors remains limited. To address this challenge, we developed a biomimetic nanobooster by incorporating cerium oxide (CeO2) nanoparticles with bacterial outer membrane vesicles (OMVs), termed CeO2@OMV. This innovative strategy overcomes the limitations of conventional radiotherapy by enhancing antigen release and improving immune cell infiltration, thereby amplifying its effectiveness in combating both primary and metastatic tumors. The biocompatibility, antitumor effects, bystander and immunomodulatory impacts of the nanoboosters were assessed by comprehensive in vitro assays and in vivo breast cancer models. Our results demonstrated that CeO2@OMVs can selectively inhibit cancer cells while protecting normal tissue upon irradiation. Additionally, the nanoboosters induced immunogenic cell death, enhanced macrophage polarization, and suppressed the growth of bystander tumors. In vivo studies demonstrated that CeO2@OMVs, when combined with radiotherapy, significantly improved local tumor control and triggered systemic immune responses, leading to substantial inhibition of both primary and distant tumors, effectively preventing new metastases. In conclusion, our CeO2@OMV nanoboosters offer a promising therapeutic strategy against metastatic breast cancer, providing a novel tool to achieve radiation-induced abscopal effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12951-025-03187-3

Cites

Statistics

Figures

Fig. 1 Preparation and characterization of CeO2@OMV nanoboosters. (A) Synthesis of CeO2@OMVs. (B) Transmission electron microscopy (TEM) image of CeO2. Scale bar: 50 nm. (C) TEM image of OMVs. Scale bar: 50 nm. (D) TEM image of CeO2@OMVs. Scale bar: 50 nm (left) and 20 nm (right). (E) Particle size distributions of OMVs. (F) Particle size distributions of CeO2@OMVs. (G) Zeta potential distribution (H) CsCl density gradient (ρ, 1.1–1.3 g/ml) centrifugation for isolation of OMVs. (I) SDS-PAGE analysis of the protein components in OMVs (25 µg/ml) and CeO2@OMVs (25 µg/ml) stained with Coomassie Brilliant Blue. PDI, polydispersity index
Fig. 1 Preparation and characterization of CeO2@OMV nanoboosters. (A) Synthesis of CeO2@OMVs. (B) Transmission electron microscopy (TEM) image of CeO2. Scale bar: 50 nm. (C) TEM image of OMVs. Scale bar: 50 nm. (D) TEM image of CeO2@OMVs. Scale bar: 50 nm (left) and 20 nm (right). (E) Particle size distributions of OMVs. (F) Particle size distributions of CeO2@OMVs. (G) Zeta potential distribution (H) CsCl density gradient (ρ, 1.1–1.3 g/ml) centrifugation for isolation of OMVs. (I) SDS-PAGE analysis of the protein components in OMVs (25 µg/ml) and CeO2@OMVs (25 µg/ml) stained with Coomassie Brilliant Blue. PDI, polydispersity indexCC BY-NC-ND · PubMed Central
Fig. 2 Cell viability and cellular uptake assays. (A) Bar chart showing the cell viability of 4T1 cancer cells and L929 normal fibroblasts after 24-hour (left panel) and 48-hour (right panel) incubation with different concentrations of CeO2@OMV. (B) Merged confocal microscopy images showing the cellular uptake of CeO2@OMV (red fluorescence) by 4T1 cells after 24-hour incubation at 25 µg/ml. Cell nuclei and cytoskeleton were labeled with DAPI (blue) and Alexa Fluor™ 488 Phalloidin (green), respectively. The yellow arrow indicates the nanoparticles’ position in proximity to the nucleus along the z-axis. Scale bar: 20 μm. (C) Bar chart showing the differential cell viability between 4T1 cancer cells and L929 normal fibroblasts under various treatments, including: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5), OMV + XR (6), CeO2@OMV + XR. XR, a single fraction of 4-Gray X-ray irradiation with 6-MV photons. Data are presented as mean ± standard deviations (SD). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant
Fig. 2 Cell viability and cellular uptake assays. (A) Bar chart showing the cell viability of 4T1 cancer cells and L929 normal fibroblasts after 24-hour (left panel) and 48-hour (right panel) incubation with different concentrations of CeO2@OMV. (B) Merged confocal microscopy images showing the cellular uptake of CeO2@OMV (red fluorescence) by 4T1 cells after 24-hour incubation at 25 µg/ml. Cell nuclei and cytoskeleton were labeled with DAPI (blue) and Alexa Fluor™ 488 Phalloidin (green), respectively. The yellow arrow indicates the nanoparticles’ position in proximity to the nucleus along the z-axis. Scale bar: 20 μm. (C) Bar chart showing the differential cell viability between 4T1 cancer cells and L929 normal fibroblasts under various treatments, including: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5), OMV + XR (6), CeO2@OMV + XR. XR, a single fraction of 4-Gray X-ray irradiation with 6-MV photons. Data are presented as mean ± standard deviations (SD). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significantCC BY-NC-ND · PubMed Central
Fig. 3 The effect of CeO2@OMV and X-ray irradiation (XR) on reactive oxygen species (ROS) production, DNA damage, and HMGB-1 expression. (A) Flow cytometric analysis of intracellular ROS production in 4T1 cancer cells (left panel) and L929 normal fibroblasts (right panel) receiving different treatments. (B) DNA damage of 4T1 cells receiving different treatments measured by γ-H2AX immunofluorescence. Green arrows indicate the γ-H2AX foci, and cell nuclei were labeled with DAPI (blue). The combination of CeO2@OMV and 4 Gy XR resulted in significantly increased γ-H2AX expression. Scale bar: 20 μm. (C) Quantitative western blot analysis of HMGB-1 expression in 4T1 cells receiving different treatments, with the highest HMGB-1 expression in the CeO2@OMV + 4 Gy XR group. The experimental groups were divided into seven: (1) Control (2), OMV (3), CeO2@OMV (4), Control + 4 Gy XR (5) OMV + 4 Gy XR (6) CeO2@OMV + 4 Gy XR (7) 10 Gy XR used as positive control. The raw western blot image is provided in Supplementary Figure S1. XR, a single fraction of X-ray irradiation with 6 MV photons. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant
Fig. 3 The effect of CeO2@OMV and X-ray irradiation (XR) on reactive oxygen species (ROS) production, DNA damage, and HMGB-1 expression. (A) Flow cytometric analysis of intracellular ROS production in 4T1 cancer cells (left panel) and L929 normal fibroblasts (right panel) receiving different treatments. (B) DNA damage of 4T1 cells receiving different treatments measured by γ-H2AX immunofluorescence. Green arrows indicate the γ-H2AX foci, and cell nuclei were labeled with DAPI (blue). The combination of CeO2@OMV and 4 Gy XR resulted in significantly increased γ-H2AX expression. Scale bar: 20 μm. (C) Quantitative western blot analysis of HMGB-1 expression in 4T1 cells receiving different treatments, with the highest HMGB-1 expression in the CeO2@OMV + 4 Gy XR group. The experimental groups were divided into seven: (1) Control (2), OMV (3), CeO2@OMV (4), Control + 4 Gy XR (5) OMV + 4 Gy XR (6) CeO2@OMV + 4 Gy XR (7) 10 Gy XR used as positive control. The raw western blot image is provided in Supplementary Figure S1. XR, a single fraction of X-ray irradiation with 6 MV photons. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significantCC BY-NC-ND · PubMed Central
Fig. 4 Activation and M1 polarization of co-cultured macrophages by CeO2@OMV and X-ray irradiation (XR). (A) Transwell design to evaluate the impact of differently treated 4T1 cells (upper insert) on co-cultured RAW264.7 macrophages (lower chamber). (B) Quantitative western blot analysis of iNOS and Arg-1 expression in RAW 264.7 macrophages co-cultured with 4T1 cells receiving different treatments. (C) Quantitative western blot analysis of TNF-α, Erk 1/2, and p- Erk 1/2 expression in RAW 264.7 macrophages co-cultured with 4T1 cells receiving different treatments. The treatment groups included: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. The raw western blot image is provided in Supplementary Figure S2 and S4. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for two consecutive days. All error bars represent standard deviations. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant
Fig. 4 Activation and M1 polarization of co-cultured macrophages by CeO2@OMV and X-ray irradiation (XR). (A) Transwell design to evaluate the impact of differently treated 4T1 cells (upper insert) on co-cultured RAW264.7 macrophages (lower chamber). (B) Quantitative western blot analysis of iNOS and Arg-1 expression in RAW 264.7 macrophages co-cultured with 4T1 cells receiving different treatments. (C) Quantitative western blot analysis of TNF-α, Erk 1/2, and p- Erk 1/2 expression in RAW 264.7 macrophages co-cultured with 4T1 cells receiving different treatments. The treatment groups included: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. The raw western blot image is provided in Supplementary Figure S2 and S4. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for two consecutive days. All error bars represent standard deviations. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significantCC BY-NC-ND · PubMed Central
Fig. 5 The bystander effect of CeO2@OMV and X-ray irradiation (XR). (A) Transwell experimental design to assess radiation-induced bystander effects (illustrating the scenario when co-cultured with macrophages). (B) Proliferation rate of bystander cells after a 24-hour incubation with conditioned media from various treatments, with or without co-culture with RAW 264.7 cells. The conditioned media were derived from 4T1 cells subjected to different treatments: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for two consecutive days. All error bars represent standard deviations. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant
Fig. 5 The bystander effect of CeO2@OMV and X-ray irradiation (XR). (A) Transwell experimental design to assess radiation-induced bystander effects (illustrating the scenario when co-cultured with macrophages). (B) Proliferation rate of bystander cells after a 24-hour incubation with conditioned media from various treatments, with or without co-culture with RAW 264.7 cells. The conditioned media were derived from 4T1 cells subjected to different treatments: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for two consecutive days. All error bars represent standard deviations. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significantCC BY-NC-ND · PubMed Central
Fig. 6 Schematic illustration, quantitative results, and representative images of bystander cells assays exposed to different conditioned mediums. These assays include (A) wound healing assay, (B) cell migration assay, and (C) cell invasion assay. In wound healing assays, wound closure (%) was quantified based on the percentage of the scratched area covered by cells at given time points. In cell migration and invasion assays, the number of migrated and invaded cells after 24-hour was quantified using ImageJ software. Original magnification 200 ×. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant. The experimental groups included: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for two consecutive days
Fig. 6 Schematic illustration, quantitative results, and representative images of bystander cells assays exposed to different conditioned mediums. These assays include (A) wound healing assay, (B) cell migration assay, and (C) cell invasion assay. In wound healing assays, wound closure (%) was quantified based on the percentage of the scratched area covered by cells at given time points. In cell migration and invasion assays, the number of migrated and invaded cells after 24-hour was quantified using ImageJ software. Original magnification 200 ×. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns, not significant. The experimental groups included: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for two consecutive daysCC BY-NC-ND · PubMed Central
Fig. 7 In vivo abscopal effect of CeO2@OMV on bilateral 4T1 tumor-bearing mice upon X-ray irradiation (XR). (A) Schematic diagram of the in vivo study design. Yellow arrow indicates intratumoral injection of PBS, OMVs or CeO2@OMVs as specified in each group. Blue arrows indicate XR sessions. (B) IVIS imaging of primary tumors on day 2 (left panel) and day 20 (right panel) in each group. Luminescent intensity of tumors was displayed by the color bar on the right side. (C) IVIS imaging of distant untreated tumors on day 7 (left panel) and day 20 (right panel) in each group. (D) Both the growth curves and harvested weights of primary tumors were significantly inhibited in the CeO2@OMV + XR group. (E) Both the growth curves and harvested weights of distant untreated tumors were significantly reduced in the CeO2@OMV + XR group. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for three consecutive days
Fig. 7 In vivo abscopal effect of CeO2@OMV on bilateral 4T1 tumor-bearing mice upon X-ray irradiation (XR). (A) Schematic diagram of the in vivo study design. Yellow arrow indicates intratumoral injection of PBS, OMVs or CeO2@OMVs as specified in each group. Blue arrows indicate XR sessions. (B) IVIS imaging of primary tumors on day 2 (left panel) and day 20 (right panel) in each group. Luminescent intensity of tumors was displayed by the color bar on the right side. (C) IVIS imaging of distant untreated tumors on day 7 (left panel) and day 20 (right panel) in each group. (D) Both the growth curves and harvested weights of primary tumors were significantly inhibited in the CeO2@OMV + XR group. (E) Both the growth curves and harvested weights of distant untreated tumors were significantly reduced in the CeO2@OMV + XR group. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for three consecutive daysCC BY-NC-ND · PubMed Central
Fig. 8 Histopathological assessment of distant tumors and lung tissues. (A) Cross sections of Hematoxylin and eosin (H&E)-stained distant tumors in each group and corresponding mitotic index. In the upper panel, dotted lines outline the tumor (T) and area of necrosis (N); Scale bar = 500 μm. In the lower panel, the average mitotic index was quantified per 10 high power fields; Scale bar = 50 μm. (B) Representative images of the proportion of tumor-infiltrating lymphocytes (TIL) in the stromal area of distant tumors in each group. Black lines outline the border between tumor and stroma. Scale bar = 50 μm. (C) Representative immunohistochemical (IHC) staining of CD4+ (upper panel) and CD8+ (lower panel) T cells infiltrates in distant tumors from each group. Scale bar = 20 μm. (D) Representative H&E staining of lung tissue section from each group. Yellow arrows indicate metastatic foci in the lungs, and there was no evidence of lung metastasis in the CeO2@OMV + XR group. Scale bar = 50 μm. The treatment groups included: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for three consecutive days
Fig. 8 Histopathological assessment of distant tumors and lung tissues. (A) Cross sections of Hematoxylin and eosin (H&E)-stained distant tumors in each group and corresponding mitotic index. In the upper panel, dotted lines outline the tumor (T) and area of necrosis (N); Scale bar = 500 μm. In the lower panel, the average mitotic index was quantified per 10 high power fields; Scale bar = 50 μm. (B) Representative images of the proportion of tumor-infiltrating lymphocytes (TIL) in the stromal area of distant tumors in each group. Black lines outline the border between tumor and stroma. Scale bar = 50 μm. (C) Representative immunohistochemical (IHC) staining of CD4+ (upper panel) and CD8+ (lower panel) T cells infiltrates in distant tumors from each group. Scale bar = 20 μm. (D) Representative H&E staining of lung tissue section from each group. Yellow arrows indicate metastatic foci in the lungs, and there was no evidence of lung metastasis in the CeO2@OMV + XR group. Scale bar = 50 μm. The treatment groups included: (1) Control (2), OMV (3), CeO2@OMV (4), Control + XR (5) OMV + XR (6) CeO2@OMV + XR. CTRL, control. XR, X-ray irradiation with 4 Gy per fraction for three consecutive daysCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 54 · Cited by 11

Metadata

Authors
Chen, S.-F., Ng, P.-L., Lai, C.-W., Wang, F.-J., Wang, Y.-C., Chen, M.-H., Tung, F.-I., & Liu, T.-Y.
Affiliations
  • Taipei Veterans General Hospital (TW)
  • National Yang Ming Chiao Tung University (TW)
  • University of Taipei (TW)
Corresponding author
  • Tung, Fu-I
  • Liu, Tse-Ying
Venue
Journal of Nanobiotechnology
Published
2025-02-12
Volume
23
Issue
1
Pages
105-105
ISSN
1477-3155 (ISSN-L)
OpenAlex
W4407391075
Cited by
11
References
54
Citations by year
2026: 8 · 2025: 3
FWCI
2.68
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Nanobiotechnology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Department of Health, Taipei City Government (11201-62-004 and 11301-62-048)
  • National Science and Technology Council (MOST 111-2221-E-A49-051-MY2, MOST 111-2811-E-A49A-007-MY2, MOST 111-2314-B-038-094)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
cerium oxide nanoparticles, bacterial outer membrane vesicles, radiotherapy, triple-negative breast cancer, metastatic breast cancer, abscopal effect, immunogenic cell death, bystander effect, macrophage polarization, systemic antitumor immunity, biomimetic nanomaterials, radiation-induced immunomodulation
MeSH terms
Bacterial Outer Membrane, Animals, Antineoplastic Agents, Cerium, Female, Humans, Mice, Inbred BALB C, Cell Line, Tumor, Mice, Nanoparticles, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer. https://app.cochat.ai/papers/10.1186/s12951-025-03187-3
The paper
Chen, S.-F., Ng, P.-L., Lai, C.-W., Wang, F.-J., Wang, Y.-C., Chen, M.-H., Tung, F.-I., & Liu, T.-Y. (2025). Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-025-03187-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.